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Background: Alzheimer’s disease (AD) is characterized by progressive memory loss and impaired cognitive
function. Early-onset familial forms of the disease (FAD) are caused by inheritance of mutant genes encoding
presenilin 1 (PS1) variants. We have demonstrated that prion promoter (PrP)-driven expression of human FAD-linked
PS1 variants in mice leads to impairments in environmental enrichment (EE)-induced adult hippocampal neural
progenitor cell (AHNPC) proliferation and neuronal differentiation, and have provided evidence that accessory cells
in the hippocampal niche expressing PS1 variants may modulate AHNPC phenotypes, in vivo. While of significant
interest, these latter studies relied on transgenic mice that express human PS1 variant transgenes ubiquitously and
at high levels, and the consequences of wild type or mutant PS1 expressed under physiologically relevant levels on
EE-mediated AHNPC phenotypes has not yet been tested.
Results: To assess the impact of mutant PS1 on EE-induced AHNPC phenotypes when expressed under
physiological levels, we exposed adult mice that constitutively express the PSEN1 M146V mutation driven by the
endogenous PSEN1 promoter (PS1 M146V “knock-in” (KI) mice) to standard or EE-housed conditions. We show that
in comparison to wild type PS1 mice, AHNPCs in mice carrying homozygous (PS1M146V/M146V) or heterozygous
(PS1M146V/+) M146V mutant alleles fail to exhibit EE-induced proliferation and commitment towards neurogenic
lineages. More importantly, we report that the survival of newborn progenitors are diminished in PS1 M146V KI
mice exposed to EE-conditions compared to respective EE wild type controls.
Conclusions: Our findings reveal that expression at physiological levels achieved by a single PS1 M146V allele is
sufficient to impair EE-induced AHNPC proliferation, survival and neuronal differentiation, in vivo. These results and
our finding that microglia expressing a single PS1 M146V allele impairs the proliferation of wild type AHNPCs in vitro
argue that expression of mutant PS1 in the AHNPC niche impairs AHNPCs phenotypes in a dominant, non-cell
autonomous manner.
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AD is pathologically characterized by the deposition of
β-amyloid (Aβ) peptides in senile plaques and neuronal
loss that leads to impairments in memory and cognitive
function. Aβ peptides are derived from larger amyloid
precursor protein (APP) by the concerted action of
BACE1 and a multiprotein complex, termed γ-secretase,
that catalyzes intramembranous proteolysis of a variety
of type I membrane substrates. Inheritance of mutations* Correspondence: ssisodia@bsd.uchicago.edu
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distribution, and reproduction in any mediumin PSEN1, PSEN2 or APP genes, encoding PS1, PS2 or
APP variants, respectively, cause early-onset, autosomal
dominant forms of familial AD (FAD) [1]. PS are the
catalytic components of the γ-secretase complex and ex-
pression of PS1 variants leads to elevations in the ratio
of Aβ42/Aβ40 peptides, leading to nucleation, oligo-
merization and neuropathogenicity of Aβ42 peptides [2].
Notwithstanding this important aspect of pathogenesis
mediated by FAD-linked PS1 variants, a number of stud-
ies have revealed that PS1 influences multiple signaling
pathways and have more global effects on neuronal
function and plasticity [3].Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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self-renewing cell population in the subgranular layer
(SGL) of the dentate gyrus (DG), functionally mature
into neurons and integrate into the hippocampal cir-
cuitry [4]. This process of adult neurogenesis has been
implicated in hippocampal function, learning and mem-
ory, and adaptation to novel environments, stress re-
sponse, depression, injury or disease [5-7]. Genetic
ablation of new born neurons in adult mice results in
gradual loss of granule cell numbers in the DG, leading
to impairments in hippocampal-dependent behaviors, in-
cluding contextual and spatial memory [8]. On the other
hand, exposure of adult rodents to an enriched environ-
ment (EE), in which animals are placed in large cages
containing running wheels, colorful tunnels and assorted
toys, increases hippocampal neurogenesis and enhances
spatial learning performance [9-11]. We have demon-
strated that transgenic mice expressing FAD-linked PS1
variants in a ubiquitous manner exhibit impairments in
EE-mediated proliferation and neuronal differentiation
of AHNSCs [12], and that these AHNSC phenotypes are
driven by non cell-autonomous mechanisms that require
mutant PS1 expression in microglia [12] and excitatory
neurons [13].
We now extend these latter observations and demon-
strate that EE-induced AHNPC proliferation and neur-
onal differentiation is also impaired in PS1 M146V KI
mice that harbor a germ line M146V mutation [14]. WeFigure 1 AHNPC proliferation in PS1 M146V KI mice following exposu
BrdU+ AHNPCs (yellow) in the SGL of PS1+/+, PS1M146V/+ or PS1M146V/ M146V m
single i.p dose of 100 mg/kg of BrdU and sacrificed 24 hr later. NeuN, gree
Two-way ANOVA followed by post-hoc Tukey test; N = 10, 10, 9 for SH animalso report that the conditioned medium of microglia
obtained from PS1 M146V KI mice impairs the prolifer-
ation of wild type AHNPCs. Finally, we report that the
survival of newborn progenitors are diminished in PS1
M146V KI mice exposed to EE-conditions compared to
respective enriched wild type control cohorts.
Results
EE-induced AHNPC proliferation in mutant PS1 KI mice
A cohort of one month old male wild type (PS1+/+), het-
erozygous (PS1M146V/+) or homozygous (PS1M146V/M146V)
mice were exposed to standard housing (SH) or EE condi-
tions for one month. At the end of one month, animals
housed under these two conditions were injected intraper-
itoneally (i.p) with a single dose of 100 mg/kg of BrdU.
Mice were sacrificed 24 hr post injection, and brain sec-
tions were subjected to immunofluoresence analysis using
a BrdU-specific antibody (Figure 1A), and the number of
BrdU+ cells in SGL was quantified. Under SH conditions,
no significant difference in BrdU+ cell numbers in the
DG were observed between PS1+/+ and PS1M146V/+ mice
(Figure 1B; P=0.644), or between PS1+/+, PS1M146V/M146V
mice (Figure 1B; P=0.266), or between PS1M146V/+ and
PS1M146V/M146V mice (Figure 1B; P=0.756). Exposure to
EE lead to a significant increase in BrdU+ cell numbers in
all three genotypes when compared to their respective
control cohorts exposed to SH conditions (Figure 1B;
P<0.01). However, and in contrast, with the a prominentre to SH or EE housing conditions. (A) Representative images of
ice, exposed to SH or EE conditions for one month, injected with a
n. Scale bar, 100 μm. (B) Quantification of total BrdU+ cells in SGL.
als, and 10, 12, 11 for EE animals (m ± SEM). ** p < 0.01.
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detected in EE versus SH PS1+/+ mice, exposure to EE lead
to only a modest 1.48- and 1.49-fold increase in BrdU+
cell numbers in PS1M146V/+ and PS1M146V/M146V mice, re-
spectively, compared with their SH cohorts. Moreover, the
BrdU+ cell numbers in the hippocampus of PS1M146V/+
and PS1M146V/M146V mice exposed to EE conditions were
significantly lower than the numbers observed in enriched
PS1+/+ mice (Figure 1B; P<0.01, EE PS1+/+ vs. EE
PS1M146V/+ and EE PS1+/+ vs. EE PS1M146V/M146V).
EE-mediated differentiation and survival of AHNCPs in
mutant PS1 KI mice
To assess the impact of the PS1 M146V KI mutation on
EE-induced differentiation of newly-born AHNPC into
neuronal or glial lineages, we exposed cohorts of PS1+/+,
PS1M146V/+ or PS1M146V/M146V mice to SH or EE condi-
tions for one month, and then injected these animals
with a single dose of BrdU (100 mg/kg). The cohorts of
PS1+/+, PS1M146V/+ or PS1M146V/M146V mice were then
returned to respective SH or EE conditions for an add-
itional 2 weeks. We chose the two week time point for
analysis because this is an accepted time window to
score for neuronal or glial lineage commitment of
AHNPCs and their survival efficiency [15]. More specif-
ically, this earlier time point allows us to score the pro-
portion or percentage of AHNPCs that express different
neuronal lineage markers, such as the early immature
(β-III tubulin), early mature (Prox1), mature (NeuroD1)
and terminally differentiated (NeuN) stages. At the end
of two weeks, the animals were sacrificed and brain sec-
tions were subjected to immunofluorescence staining with
anti-BrdU antibodies combined either with antibodies
against: TuJ1 (βIII tubulin), a marker of both early imma-
ture and mature neurons; Prospero-related homeobox 1
(Prox1), a marker of early and late mature neuronal line-
ages; NeuroD1, a marker for mature neuronal lineages;
NeuN, a marker for mature neurons; or glial fibrillary
acidic protein (GFAP) and s100β, markers for astrocytes.
Representative images are shown in Figure 2A.
Quantification of BrdU+ cells co-labeled with lineage
specific markers showed no significant differences across
all the genotypes under SH conditions (Figure 2B.i-vi). Ex-
posure of PS1+/+ mice to EE resulted in a 1.366-fold in-
crease, albeit insignificant, in the percentage of BrdU+/βIII
tubulin+ cells compared with the SH cohort (Figure 2B.i;
P=0.075; SH PS1+/+ vs. EE PS1+/+). Similarly, in compari-
son with the cohorts maintained in SH conditions, expos-
ure of PS1M146V/+ or PS1M146V/M146V mice to EE
conditions resulted in an increase in the percentage of
BrdU+/βIII tubulin+ cells by 1.364- and 1.267-fold,
respectively (Figure 2B.i; P=0.091, SH PS1M146V/+ vs. EE
PS1M146V/+; P=0.0147, SH PS1M146V/M146V vs. EE
PS1M146V/M146V).Exposure of PS1+/+ mice to EE resulted in a significant,
1.474-fold increase in the percentage of BrdU+/Prox1+ cells
compared to SH cohorts (Figure 2B.ii; P=0.04; SH PS1+/+
vs. EE PS1+/+). In contrast, in comparison with the cohorts
maintained in SH conditions, exposure of PS1M146V/+ or
PS1M146V/M146V mice to EE conditions resulted in resulted
in an insignificant 1.316- and 1.15-fold increase in the per-
centage of BrdU+/Prox1+ cells, respectively (Figure 2B.ii;
P=0.078, SH PS1M146V/+ vs. EE PS1M146V/+; P=0.299, SH
PS1M146V/M146V vs. EE PS1M146V/M146V).
Analysis of cells colabeled with BrdU and the late
neuronal markers, NeuroD1 and NeuN revealed that ex-
posure of PS1+/+ mice to EE resulted in a significant
increase by 1.62- and 1.37-fold in the percentage of
BrdU+/NeuroD1+ or BrdU+/NeuN+ double labeled cells,
compared with SH cohorts, respectively (Figure 2B.iii-iv;
P=0.012 BrdU+/NeuroD1+ and 0.027 BrdU+/NeuN+; SH
PS1+/+ vs. EE PS1+/+). On the other hand, exposure of
PS1M146V/+ and PS1M146V/M146V mice to EE conditions
resulted in a insignificant increase in the percentage of
BrdU+/NeuroD1+ or BrdU+/NeuN+ double labeled cells
(Figure 2B.iii-iv; P=0.146, SH PS1M146V/+ vs. EE PS1M146V/+
and P=0.703, SH PS1M146V/M146V vs. EE PS1M146V/M146V for
BrdU+/NeuroD1+; P=0.291, SH PS1M146V/+ vs. EE
PS1M146V/+ and P=0.091, SH PS1M146V/M146V vs. EE
PS1M146V/M146V for BrdU+/NeuN+).
Importantly, a significant reduction in the percentage
of BrdU+/NeuroD1+ and BrdU+/NeuN+ double labeled
cells was observed between PS1+/+ versus PS1M146V/+ or
PS1M146V/M146V groups that were exposed to EE condi-
tions (Figure 2B.iii-iv; P=0.03 for BrdU+/NeuroD1+ and
P=0.045 for BrdU+/NeuN+ in EE PS1+/+ vs. EE
PS1M146V/+ mice; and P=0.006 for BrdU+/NeuroD1+
and P=0.024 for BrdU+/NeuN+ in EE PS1+/+ vs. EE
PS1M146V/M146V mice). Examination of glial lineages re-
vealed no significant changes in the percentage of
BrdU+/GFAP+ or BrdU+/s100β+ double-labeled cells
between SH versus EE groups or within EE groups,
across all three genotypes (Figure 2B.v-vi).
To determine whether the observed impairments in
neuronal differentiation of AHNPCs in mutant PS1 KI
mice (Figure 2), might be a reflection of decreased sur-
vival of new born progenitors under EE conditions, we
calculated the fraction of surviving BrdU+ cells in the
SGL and granule cell layers as a percentage of the
BrdU+ cell numbers remaining after 2 weeks compared
to the numbers obtained when animals were sacrificed
24 hr after single dose of 100 mg/kg of BrdU
(Figure 1B). While 50.56±2.17% of new born, BrdU-
labeled AHNPCs survived for 2 weeks in PS1+/+ mice,
a lower percentage of only 45.11±1.76% and 41.59
±1.67% survived in PS1M146V/+ and PS1M146V/M146V
mice, respectively (Figure 3). One-way ANOVA
followed by post-hoc LSD test revealed a near-
Figure 2 EE-induced differentiation of AHNPC in PS1 M146V KI mice. (A) Representative images of BrdU+/Prox1+ (A.i), BrdU+/β-III tubulin+
(A.ii), BrdU+/NeuroD1+ (A.iii), BrdU+/NeuN+ (A.iv), BrdU+/GFAP+ (A.v) or BrdU+/s100β+ (A.vi) co-labeled cells in PS1+/+ mice exposed to EE
condition, injected with a single i.p dose of 100 mg/kg of BrdU and sacrificed 2 weeks later. Scale bar, 25 μm. Inserts inside each panel shows
subfield of images captured through individual channels and the respective overlays highlighting cells co-labeling of BrdU and mentioned
antigenic marker of differentiation. (B) Quantification of co-labeled cells with BrdU and markers of differentiation in DG of PS1+/+, PS1M146V/+ or
PS1M146V/ M146V mice exposed to SH or EE housing condition. Two-way ANOVA followed by post-hoc Tukey test for analyzing multiple groups or
T-test; N = 7, 8 (SH vs. EE, PS1+/+); 6, 8 (SH vs. EE, PS1M146V/+); 6, 6 (SH vs. EE, PS1M146V/ M146V) (m ± SEM). * p < 0.05, ** p < 0.01, # p = 0.075.
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vs. PS1M146V/+ mice and a significant P value of 0.005
in comparisons of PS1+/+ vs. PS1M146V/M146V mice.
Collectively, these observations lead us to conclude
that endogenous PSEN1 promoter-driven expression of
mutant PS1 decreases the survival of new born
AHNPCs following EE.
Conditioned medium (CM) from microglia expressing the
PS1 M146V KI variant impairs proliferation of AHNPCs
in vitro
In earlier studies, we reported that both proliferation
and neuronal cell fate commitment of AHNPCs from
wild type mice was impaired by the addition of CM from
IL-4-treated microglia obtained from transgenic mice
that express PrP-driven FAD-linked PS1 mutants [12].
To test whether the CM from microglia obtained from
PS1M146V/+ mice exhibit similar properties on AHNPCs,we bred either PS1+/+ or PS1M146V/M146V mice to
Cx3Cr1GFP/GFP reporter mice in which cDNA encoding
enhanced GFP (eGFP) has been knocked-in downstream
of the fractalkine receptor Cx3Cr1 promoter [16], lead-
ing to eGFP expression exclusively in CNS microglia
with ramified processes (Figure 4A), but not in GFAP-
expressing astrocytes (Figure 4B). Mixed glial cultures
from neonatal PS1+/+ x Cx3Cr1GFP/+ and PS1M146V/+ x
Cx3Cr1GFP/+ lines were established and eGFP+ microglia
fraction was isolated by flow cytometry to establish pure
cultures of microglia (Figure 4C and D). The GFP+
microglia established from PS1+/+ x Cx3Cr1GFP/+ and
PS1M146V/+ x Cx3Cr1GFP/+ mice were activated with IL4
and the CM was incubated with AHNPCs from PS1+/+
mice that were cultured as neurospheres (Figure 4E).
The proliferative capacity of AHNPCs was determined
using a BrdU-uptake assay, as described earlier [12]. We
observed that the extent of BrdU incorporation was
Figure 3 Survival of AHNPC from PS1 M146V KI mice following
exposure to EE housing conditions. Histogram shows the survival
fraction of BrdU+ AHNPCs in SGL and granular cell layers of PS1
M146V KI following exposure to EE housing conditions. Survival
fraction, calculated as a percentage of the BrdU+ cell numbers
remaining after 2 weeks over the numbers obtained when animals
were sacrificed 24 hr after single dose of 100 mg/kg of BrdU.
ANOVA followed by post-hoc LSD test; N = 8, 8, 6 for EE PS1+/+,
PS1M146V/+ and PS1M146V/ M146V mice, respectively. ** p < 0.01;
# p = 0.051.
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glia CM from PS1+/+ x Cx3Cr1GFP/+ and PS1M146V/+ x
Cx3Cr1GFP/+ mice after 1 or 3 days, but by day 6, the
proliferation of AHNPC was significantly reduced in the
presence of CM from PS1M146V/+ x Cx3Cr1GFP/+ micro-
glia (Figure 4F; P<0.01). These results reveal that the im-
pairments in proliferation of cultured AHNPCs observed
earlier with CM from transgenic mice overexpressing
FAD-linked PSEN1 variants [12], can be recapitulated
when an FAD-linked PS1 mutation is expressed at
physiological levels when driven by the endogenous
PSEN1 promoter.
Discussion
Earlier studies have shown that hippocampal neurogen-
esis declines with age and this reduction has been linked
with impaired learning, memory, and deterioration of
cognitive ability in the elderly [17-19]. In this regard, a
recent report revealed that hippocampal neurogenesis is
markedly reduced in patients with AD [20], findingswhich suggest that reductions in the number of new
born granule cell neurons might enhance the rate of de-
cline in hippocampal function and cognitive ability, and
thereby significantly contribute to AD type dementia. In
order to assess the potential role of FAD-linked PS1 var-
iants on adult hippocampal neurogenesis, we and others
have examined transgenic mice expressing PS1 variants
driven by heterologous promoters [12,21-23]. However,
a consensus regarding the role of mutant PS1 on
AHNPC phenotypes has not emerged, and likely reflects
the impact of overexpressing the transgenes in restricted
cellular populations. For example, expression of the
FAD-linked PS1P117L mutant driven by the neuron-
specific enolase promoter failed to promote neurogen-
esis under SH conditions [23], and impaired survival of
AHNPCs and neuronal differentiation under EE con-
ditions [22]. However, expression of FAD-linked
PS1A246E mutant driven by the neuron-specific Thy-1
promoter on a PS1−/− background resulted in an in-
crease in proliferation and decrease in survival of
AHNPCs with no apparent reduction in net neuronal
differentiation in animals exposed to SH conditions [21].
On the other hand, we reported that transgenic mice ex-
pressing the FAD-linked PS1ΔE9 and PS1M146L vari-
ants driven by the ubiquitously active PrP-promoter, fail
to exhibit EE-induced AHNPC proliferation or differen-
tiation towards neuronal lineage, with no noticeable
changes in these parameters in SH conditions compared
to mice expressing hPS1WT [12]. In this regard, PS1 has
been shown to be expressed endogenously in AHNPCs
[24], neurons [25], cerebral vasculature [26], glia and oli-
godendrocytes [12,27]. Thus, while it seems reasonable
that ubiquitous, PrP promoter-driven of mutant PSEN1
transgenes reflects the expression patterns of endogen-
ous PSEN1, there remain concerns regarding expression
levels and regulation in specific CNS cell types.
In order to address these potential concerns, we asked
whether the EE-mediated impairments on AHNPC pro-
liferation and neuronal differentiation that we docu-
mented in transgenic mice expressing FAD-linked
PS1could be validated in “knock-in” mice harboring an
FAD-linked PS1 mutation in the endogenous PSEN1
locus, and we now offer several important insights.
First, we show that EE-induced proliferation of
AHNPCs is impaired in both PS1M146V/+ and PS1M146V/
M146V animals, similar to our earlier findings in PrP-
driven FAD-linked mutant PSEN1 transgenic mice [12].
Interestingly, under SH conditions, we also observed a
moderate reduction in proliferation of AHNPCs in
PS1M146V/+ and PS1M146V/M146V mice compared with
wild type animals.
Second, we failed to detect significant changes in early
immature and late neuronal lineages (BrdU+/βIII tubulin
or BrdU+/Prox1, respectively) or glial lineages following
Figure 4 Microglia conditioned media from PS1 M146V KI mice impairs proliferation of AHNPCs. Representative image eGFP+ microglia
(green) with ramified process in DG of PS1M146V/+ x Cx3Cr1GFP/+ mice (A) and are negative for astrocytic marker, GFAP (red) (B). Bright field (C) and
fluorescent (D) images of flow cytometry sorted primary eGFP+ cultures established from neonatal brains of PS1M146V/+ x Cx3Cr1GFP/+ mice. Scale
bar, 25 μm. Bright field image of AHNPCs grown as neurospheres from PS1+/+, mice (E). Scale bar, 50 μm. (F) Proliferation achieved by PS1+/+
AHNPCs following treatment with CM collected from IL-4 activated or PS1+/+ x Cx3Cr1GFP/+ or PS1M146V/+ x Cx3Cr1GFP/+ microglia. Graph shows
the extent of BrdU uptake in AHNPCs observed on days 1, 3 and 6. T-test; N = 3 independent cultures, with quadruplicates for each time point
(m ± SEM). ** p < 0.01.
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percentage of new born progenitors that differentiated
towards mature neuronal NeuN+ and NeuroD1+ line-
ages in PS1M146V/+ and PS1M146V/M146V mice. The lack
of obvious changes in immature neuronal lineages corre-
lates with the observations reported earlier in FAD-
linked PSEN1P264L KI mice [28]. Consistent with the
reduction in the number of new born neurons generated
under EE conditions, the numbers of BrdU+ cells that
survive two weeks post labeling were also diminished in
PS1M146V/+ and PS1M146V/M146V mice. It should be noted
that we chose a two week time point for these latter ana-
lysis in order to score neuronal or glial lineage commit-
ment of AHNPCs and their survival efficiency. The
limitation of this analysis is that cells expressing mature
neuronal markers may not be functionally integrated
into the hippocampal network.
It is presently unclear whether the reduction in
AHNPC proliferation and mature neuronal differenti-
ation in PS1M146V/+ and PS1M146V/M146V mice are a re-
flection of reductions in PS1 “activity”, but earlier
studies by Wang and colleagues offer an important
insight [29]. In the latter studies, AHNPC proliferation
in standard housed PS1M146V/- mice, wherein the mutant
allele was placed in a PSEN1 KO background, exhibited
significant reductions in both proliferation and neuro-
genic potential of AHNPC compared with PS1M146V/+
mice [29]. The authors concluded that wild-type PS1may play a “protective” role over the effects of the mu-
tant M146V variant. While the nature of the PS1-
dependent “activity” remains to be ascertained, our dem-
onstration that lowering the levels of wild-type PS1 leads
to reduced AHNPC proliferation and neuronal differen-
tiation studies, taken together with the findings reported
by Wang and colleagues [29], would be consistent with
the idea that mutant PS1 exhibits a partial “loss of func-
tion”, as has been proposed earlier [30].
Third, we report that the survival of BrdU-labeled
AHNPCs from PS1M146V/+ and PS1M146V/M146V mice ex-
posed to EE were significantly reduced compared with
PS1+/+mice. While the molecular mechanism(s) under-
lying this aspect of mutant PS1 function is presently un-
clear, evidence from several earlier studies have accrued
that support our observations [31-33]. For example, Guo
et al. [14] reported that hippocampal neurons in
PS1M146V/M146V mice exhibit enhanced susceptibility to
kianate-induced necrosis and that primary neurons from
these mice showed enhanced sensitivity to glutamate-
induced excitotoxicity. These results in PS1M146V/M146V
mice were confirmed independently in PrP promoter-
driven transgenic mice expressing the L286V variant
[31]. At a mechanistic level, it has been reported that
reported that PS1M146V/M146V mice exhibit disrupted
intracellular Ca2+ signaling in neurons [33], suggesting
that neurons expressing mutant PS1 variants have a
lower threshold for excitotoxicity-mediated degeneration
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enhanced vulnerability of excitatory neurons in layer 2
(ECL2) of the entorhinal cortex in transgenic mice ex-
pressing the FAD-linked PS1ΔE9 variant following
perforant pathway (PP) transection, compared with PP-
lesioned transgenic mice expressing wild-type human
PS1 [35].
Finally, we report that CM of microglia from
PS1M146V/+ mice inhibits proliferation of AHNPCs de-
rived from PS1+/+mice. These findings support our earl-
ier observations using CM of microglia from mice
expressing PrP-driven PSEN1 transgenes [12]. The iden-
tity of the factors in mutant microglia CM and signaling
pathways that are responsible for suppression of
AHNPC proliferation are not fully understood. However,
we showed earlier that eotaxin (or CCL11), Cxcl16, lep-
tin and TIMP-1 (Tissue Inhibitor of Metalloprotease)
are factors that were consistently elevated in the CM
from microglia expressing FAD-linked PS1ΔE9 and
PS1M146L variants [12]. In this regard, Wyss-Coray and
colleagues [36] have offered a tantalizing insight. It is
well-established that the proliferation and differentiation
of AHNPC declines precipitously as a function of age
[10], and Villeda et al. [36], sought to identify blood-
borne factors in the systemic milieu that inhibit or pro-
mote adult neurogenesis in an age-dependent fashion in
mice. One factor that was significantly elevated in the
plasma of old mice was CCL11 that binds to, and acti-
vates the CCR3 chemokine receptor that is expressed by
AHNPCs [37]. The nature of signaling pathways in
AHNPCs that are activated upon binding of CCL11 or
other factors secreted by microglia remain to be deter-
mined, and are areas of active investigation.
Conclusion
We have documented that the EE-mediated impairments
of proliferation, differentiation and survival of AHNPCs
in mice with a knock-in of an FAD-linked PSEN1 muta-
tion fully recapitulates the findings observed in trans-
genic mice expressing PrP-driven FAD-linked PSEN1
transgenes. These findings lead us to conclude that the
memory deficits and cognitive decline in patients har-
boring PSEN1 variants is a reflection not just of an in-
crease in the ratio of Aβ42 to Aβ40, but to impairments




PS1+/+, PS1M146V/M146V KI mice [14], and Cx3Cr1GFP/
GFP [16] were maintained in (C3H/HeJ x C57BL/6J F3) x
C57BL/6J n1 background. PS1+/+ were crossed to
PS1M146V/M146V KI mice to obtain PS1M146V/+ line. The
data are reported as mean ± standard error of mean(m ± SEM). Two-way ANOVA test (SPSS ver. 12),
were performed for comparisons of quantitative data
while analyzing data from multiple groups on AHNPC
proliferation or differentiation studies. Tuckey or LSD
test were used as a post-hoc analysis. T-test (Unpaired)
was performed while comparing data from two inde-
pendent data sets. Values of p < 0.05 were used as the
criterion for statistical significance. Animal experi-
ments were conducted in accordance with institu-
tional and National Institutes of Health guidelines.
EE setting and BrdU injections
For exposure to EE, cohorts of mentioned 1 month old
male transgenic, wild type or PS1 M146V KI (heterozy-
gous or homozygous) animals were housed in large
cages containing running wheels, tunnels, toys, and
chewable materials for 3 h a day for 1 month. Control
groups of animals were maintained in standard labora-
tory housing conditions. Mice received a single i.p. injec-
tion of BrdU (100 mg/kg, Sigma, St. Louis, MO) on the
last day of the enrichment. Half of the mice in each
group were sacrificed 1 day after the injection to deter-
mine progenitor proliferation as described earlier [12].
For AHNPC differentiation studies, mice were allowed
to continue under standard or EE conditions for 2 weeks
and processed to determine survival and neuronal differ-
entiation of the newborn cells.
Tissue processing, estimation of proliferation and
differentiation of AHNPCs
Tissue preparation, and immunofluorescent labelling for
BrdU, neuronal nuclei (NeuN), β-III tubulin, Prox1,
NeuroD1, s100β protein and Glial Fibrillary Acidic Protein
(GFAP) were performed as described previously [12]. The
antibodies used were rat anti-BrdU (1:100, Accurate
Chemical & Scientific Corporation, Westbury, NY), mouse
anti-NeuN (1:500, Chemicon, Temecula, CA), and rabbit
anti-GFAP (1:500, Dako, Fort Collins, CO). The fluores-
cent secondary antibodies used were biotinylated donkey
anti-rat IgG; Cy2-conjugated Streptavidin; donkey anti-
mouse IgG conjugated with Cy5; donkey anti-rabbit IgG
conjugated with Cy3 (all 1:250, Jackson ImmunResearch,
West Grove, PA).
Tissue preparation and immunostaining procedures
45 μM coronal sections of the brain were cut on a dry-
ice cooled sliding microtome block (Leica, Wtzlar,
Germany), serial sections spanning DG were collected in
two rows of 24-well dish and stored at −20°C in a cryo-
protective buffer and free floating sections were
processed for immunohistochemistry or immunofluo-
resence as described previously [12], using the following
primary antibodies: α-NeuN monoclonal antibody
(1:800; Millipore, Temecula, CA), α-Prox1 polyclonal
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rat monoclonal antibody (1:400; Accurate Chemical,
Westbury, NY), α-βIII Tubulin TUJ1 monoclonal anti-
body (1:500; Covance, Emeryville, CA), α-GFAP
polyclonal antibody (1:500; Dako, Fort Collins, CO)
or α-s100β rabbit polyclonal antibody (1:500; Abcam,
Cambridge, MA). To obtain total BrdU+ cell counts or
co-labeling of BrdU with lineage specific antigens, every
sixth and twelfth well sections from the 24-well plate,
spanning the DG were stained with α-BrdU antibodies,
and visualized using DyLight-549 conjugated donkey α-
rat or α-rabbit antibody, respectively (1:400; Jackson
ImmunoResearch, West Grove, PA). DNA denaturation,
neutralization, blocking and washing steps for BrdU
staining were followed as described earlier [12]. For
double-labeling, a combination of DyLight-488, 549 or
649 conjugated secondary antibodies were used. Brain
sections were visualized and imaged using an Olympus
DSU Spinning disk inverted confocal microscope sup-
ported with EM-CCD Hamamatsu camera (Olympus
Optical, Tokyo, Japan). Images at each wavelength were
collected separately (DyLight-549, 555/617 nm), using a
separate and specific excitation filter under x10 (0.4 NA,
water), x20 (0.7 NA, water) or x40 (1.15 NA, water) ob-
jectives. Image acquisition settings were equivalent for
all specimens, and were taken and recorded using Slide
Book Software (Intelligent Imaging Innovations, Denver,
CO). For estimating total BrdU+ or total double labeled
cells with lineage specific markers, series of systematic-
ally selected every sixth section were stained and cells
were counted throughout the coronal section in extent
of the DG, by collecting images under x40 (1.15 NA,
water) objective, equipped with Optronics Microfire
CCD camera (Optronics, Goleta, CA) or imported from
Slide Book library using DSU Spinning disk inverted
confocal microscope. Cells were excluded from being
counted when they intersected the top focal plane of the
section as per the modified stereological procedure
[38-40], and the sum of the counts was multiplied by six
to obtain an estimate on total numbers. For co-labeling
analysis of differentiated BrdU+ cell type, phenotype of
50 BrdU+ cells per animal were determined [12].
AHNPC cultures, primary microglial cultures and
proliferation assays
AHNPCs that give rise to neurospheres were cultured
from dissected hippocampal tissue of 8 weeks old male
PS1+/+ mice as described, previously [12]. In brief, single
cell suspension from hippocampal tissue (~ 4 × 105 vi-
able cells/animal), were seeded in serum free culture
media at a cell density of 50 cells/μl (SFM; Neurobasal
medium containing 100 U/ml penicillin/streptomycin, 2
mM L-glutamine, 10 μg/ml of heparin, 20 ng/ml of b-
FGF, 100 ng/ml of EGF and 2% B-27 supplement(Invitrogen, Carlsbad, CA)). Cultures were maintained at
37°C in 5% CO2/balance air. Proliferating neurospheres
started to appear in about 10–12 days. To obtain single
cell suspensions, the neurospheres were dissociated by
trituration using Neurocult chemical dissociation solu-
tion (Stem cell tech, Toronto, Canada) and cultured
through multiple passages. Primary cultures of mixed
glia cells were prepared from hippocampus of newborn
PS1+/+ or PS1M146V/+ mice according to previously de-
scribed procedure [41]. In brief, hippocampal tissue from
8 to 16 days old neonatal pups was dissected under
dissecting microscope (Leica GZ6, Germany). Tissues
from a minimum of 6 animals were pooled, minced with
scissors and incubated in PBS containing 0.25% trypsin
and 0.5 mM EDTA, at 37°C for 25 min. The suspension
was filtered through 100 μm nylon mesh, washed with
cold PBS and plated at a density of 2 × 107 cells in
DMEM, 10% FBS, 1% penicillin/streptomycin and 1% L-
glutamine. 5 days later microglial cells were shaken off
the primary mixed glial cell cultures (250 rpm for 3 hrs
at 37°C). Cells were collected by centrifugation, re-
suspended in PBS containing 0.2% FBS and eGFP+
microglia were enriched by flow cytometry (BD
FACSAria, The University of Chicago Flow Cytometry
Facility). Purified microglial cells were plated in culture
media supplemented with 5 ng/ml recombinant mouse
macrophage-colony stimulating factor (PeproTech,
Rocky Hill, NJ) and used for subsequent studies. 3 × 105
microglial cells/well in a 6 well dish were treated with 10
ng/ml of IL-4 (PeproTech, Rocky Hill, NJ) for 24 hrs,
later washed and CM was collected in SFM for 24 hrs
after initial stimulation. Effect of CM on AHNPC prolif-
eration was determined by BrdU uptake assay as de-
scribed earlier [12].
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